Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-25 @ 4:12 AM
NCT ID:
NCT03335020
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of fibromuscular dysplasia (FMD), and/or segmental arterial mediolysis (SAM), and/or spontaneous coronary artery dissection (SCAD), and those with atherosclerosis, and normal individuals.
* Adult male and non-pregnant female patient 18-100 years of age.
* Patients who are able and willing to sign the informed consent will be enrolled.
Exclusion Criteria:
* Missing records to determine whether or not they have fibromuscular dysplasia (FMD), and/or segmental arterial mediolysis (SAM), and/or spontaneous coronary artery dissection (SCAD), and those with atherosclerosis, and normal individuals.
* Patients who do not accept to participate in research studies.
* Prior contraindication to contrast agent.
* Women who are breastfeeding or pregnant
* Patients less than 18 yo
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03335020
Study Brief:
Protocol Section:
NCT03335020